$SRNE honestly though, youre being negative. He isnt responsible for share price, and they have been WAY more forthcoming with PR's. The only thing I would put against him is delivery on expected timelines for submissions. But beyond that, he can't control the FDA or Anvisa. It takes bio pharm companies years to do what he has done in months...I'm not saying he is great, but if the share price was 20 right now, with the same information and news, garuntee you would vote for his award.
$SRNE How are you guys voting? I like Henri but for lack of focus, too much hype, no delivery and PPS still at 10s means he is not getting performance award from me. Maybe next time!
View original message
  • 1
1 Like